BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9022728)

  • 1. PAPNET Testing System. Technical update.
    Denaro TJ; Herriman JM; Shapira O
    Acta Cytol; 1997; 41(1):65-73. PubMed ID: 9022728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET Testing System.
    Halford JA; Wright RG; Ditchmen EJ
    Acta Cytol; 1997; 41(1):79-81. PubMed ID: 9022730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of interactive cytologic screening. Automating the search, not the interpretation.
    Mango LJ
    Acta Cytol; 1997; 41(1):93-7. PubMed ID: 9022733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency of a double PAPNET scan of cervical smears.
    Jenny J; Isenegger I; Boon ME; Husain OA
    Acta Cytol; 1997; 41(1):82-7. PubMed ID: 9022731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
    Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
    Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAPNET testing for HSILs. The few cell/small cell challenge.
    Solomon HM; Frist S
    Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of unsuspected abnormalities by PAPNET-assisted review.
    Mitchell H; Medley G
    Acta Cytol; 1998; 42(1):260-4. PubMed ID: 9479349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of laboratory false negative smears by the PAPNET cytologic screening system.
    Mitchell H; Medley G
    Acta Cytol; 1998; 42(1):265-70. PubMed ID: 9479350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated rescreening in cervical cytology. Mathematical models for evaluating overall process sensitivity, specificity and cost.
    Kaminsky FC; Benneyan JC; Mullins DL
    Acta Cytol; 1997; 41(1):209-23. PubMed ID: 9022745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL; Acosta D; Peters RK
    Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of PAPNET-assisted vs. conventional Pap smear evaluation in primary screening of cervical smears.
    Meerding WJ; Doornewaard H; van Ballegooijen M; Bos A; van der Graaf Y; van den Tweel JG; van der Schouw YT; Habbema JD
    Acta Cytol; 2001; 45(1):28-35. PubMed ID: 11213501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the PAPNET system for prescreening triage of cervicovaginal smears.
    Ashfaq R; Saliger F; Solares B; Thomas S; Liu G; Liang Y; Saboorian MH
    Acta Cytol; 1997; 41(4):1058-64. PubMed ID: 9250299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The PAPNET system in cytological rescreening of cervical smears].
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Minerva Ginecol; 1997 Apr; 49(4):139-45. PubMed ID: 9206764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the TracCell system in mapping Papanicolaou-stained cytologic material.
    Grohs DH; Dadeshidze VV; Domanik RA; Gombrich PP; Olsson LJ; Pressman NJ
    Acta Cytol; 1997; 41(1):144-52. PubMed ID: 9022737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observer variation in cytologic grading for cervical dysplasia of Papanicolaou smears with the PAPNET testing system.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; van den Tweel JG
    Cancer; 1999 Aug; 87(4):178-83. PubMed ID: 10455204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.